|
Cadazolid
|
|
1025097-10-2
|
|
5-Hydroxyindole-3-acetic Acid
|
|
54-16-0
|
|
Dimethyl methylsuccinate
|
|
1604-11-1
|
|
3,4,9,10-Perylenetetracarboxylic diimide
|
|
81-33-4
|
|
Roledumab (anti-RHD)
|
|
1174008-79-7
|
|
Bimagrumab (anti-ACVR2B)
|
|
1356922-05-8
|
|
Cy5 DBCO chloride
|
|
2182601-72-3
|
|
Ranibizumab (anti-VEGFA)
|
|
347396-82-1
|
|
LDC 000067
|
|
1073485-20-7
|
|
WAY-327111
|
|
615273-95-5
|
|
Datelliptium chloride hydrochloride
|
|
157000-76-5
|
|
Flanvotumab (anti-TYRP1)
|
|
1188277-05-5
|
|
WAY-326812
|
|
442898-48-8
|
|
Galiximab (anti-CD80)
|
|
357613-77-5
|
|
(S)-8-Bromochroman-4-amine hydrochloride
|
|
1810074-67-9
|
|
Mal-PEG1-NHS ester
|
|
1807518-72-4
|
|
5-(hydroxyphenyl)-10,15,20-phenylporphyrin
|
|
87345-22-0
|
|
Amberlyst A21 free base
|
|
9049-93-8
|
|
Concizumab (anti-TFPI)
|
|
1312299-39-0
|
|
Tesidolumab (anti-Complement C5)
|
|
1531594-08-7
|
|
Xentuzumab (anti-IGF1)
|
|
1417158-65-6
|
|
Lacnotuzumab (anti-M-CSF)
|
|
1831128-32-5
|
|
Ladiratuzumab (anti-SLC39A6)
|
|
1629760-28-6
|
|
Narsoplimab (anti-MASP2)
|
|
2108782-45-0
|
|
WAY-327936
|
|
620103-74-4
|
|
2,2,2-Trifluoro-1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethanone
|
|
1004294-77-2
|
|
(R)-(-)-1,1'-Bi-2-naphthol Bis(trifluoromethanesulfonate)
|
|
126613-06-7
|
|
8-(Trifluoromethyl)quinoline-5-carboxylic acid
|
|
253787-47-2
|
|
4-Bromo-2-fluorobenzaldehyde
|
|
57848-46-1
|
|
Chrysophenine
|
|
2870-32-8
|
|
Vasicine hydrochloride
|
|
7174-27-8
|
|
Tisotumab (anti-F3)
|
|
1418628-81-5
|
|
Vopratelimab (anti-ICOS)
|
|
2039148-04-2
|
|
Gadolinium trihydride
|
|
37280-14-1
|
|
Strong acid cation exchange resin (NA)
|
|
63182-08-1
|
|
Basimglurant
|
|
802906-73-6
|
|
Biotin-PEG2-acid
|
|
1365655-89-5
|
|
Methyl 2,4-dioxo-4-phenylbutanoate
|
|
20577-73-5
|
|
3,5-Dimethyl-4-methoxybenzonitrile
|
|
152775-45-6
|
|
Narnatumab (anti-RON)
|
|
1188275-92-4
|
|
WAY-330324
|
|
901031-81-0
|
|
(R)-STU104
|
|
2767124-77-4
|
|
4-Chloro-2,6-pyridinedicarboxylic Acid
|
|
4722-94-5
|
|
BI-1015550
|
|
1423719-30-5
|
|
Mogamulizumab (anti-CCR4)
|
|
1159266-37-1
|
|
Rosmantuzumab (anti-RSPO3)
|
|
1684393-04-1
|
|
Ianalumab (anti-TNFRSF13C)
|
|
1929549-92-7
|
|
Quetmolimab (anti-CX3CL1)
|
|
2084037-83-0
|
|
2,2-Dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one
|
|
20348-21-4
|
|
Cannabidivarin
|
|
24274-48-4
|
|
Cesium hexafluorophosphate
|
|
16893-41-7
|
|
2′,7′-Bis(2-carboxyethyl)-5(6)-carboxyfluorescein
|
|
85138-49-4
|
|
Apamistamab (anti-PTPRC)
|
|
2097132-02-8
|
|
Sirtratumab (anti-SLITRK6)
|
|
1824663-82-2
|
|
2-Bromophenylacetic acid
|
|
18698-97-0
|
|
(2-Fluorophenyl)(2-(methylamino)-5-nitrophenyl)methanone
|
|
735-06-8
|
|
Amberlite IRA-900
|
|
9050-97-9
|
|
Oxelumab (anti-TNFSF4)
|
|
1186098-83-8
|
|
Zagotenemab (anti-Tau)
|
|
2019133-28-7
|
|
Amylopectin from maize
|
|
9037-22-3
|
|
Lexatumumab (anti-TNFRSF10B)
|
|
845816-02-6
|
|
3-Fluoro-5-(trifluoromethyl)picolinonitrile
|
|
80194-71-4
|
|
tert-butyl (1R)-1-amino-3-azabicyclo[3.1.0]hexane-3-carboxylate
|
|
1272757-54-6
|
|
Bivatuzumab (anti-CD44v6)
|
|
214559-60-1
|
|
Lumiliximab (anti-FceR2)
|
|
357613-86-6
|
|
Vorsetuzumab (anti-CD70)
|
|
1165740-62-4
|
|
Tamrintamab (anti-DPEP3)
|
|
2148325-59-9
|
|
Cinpanemab (anti-Alpha-synuclein)
|
|
2094516-02-4
|
|
Cy5.5
|
|
210892-23-2
|
|
D-Cycloserine
|
|
68-41-7
|
|
DIPHENYLETHOXYMETHYLSILANE
|
|
1825-59-8
|
|
6,7-Dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Perchlorate
|
|
1334529-08-6
|
|
trans-cyclohexane-1,3-dicarboxylic acid
|
|
2305-30-8
|
|
Itolizumab (anti-CD6)
|
|
1116433-11-4
|
|
Ragifilimab (anti-TNFRSF18)
|
|
2207590-51-8
|
|
Tusamitamab (anti-CEACAM5)
|
|
2349294-95-5
|
|
Idactamab (anti-SLC1A5)
|
|
2245205-37-0
|
|
Ravulizumab (anti-Complement C5)
|
|
1803171-55-2
|
|
KWAR23 (anti-SIRPg)
|
|
2243227-60-1
|
|
WAY-327360
|
|
687573-14-4
|
|
Bexmarilimab (anti-STAB1)
|
|
2259301-27-2
|
|
WAY-326432
|
|
870762-82-6
|
|
Sonepcizumab (anti-Sphingosine-1-phosphate)
|
|
1031360-18-5
|
|
N1-methylnicotinamide
|
|
3106-60-3
|
|
WAY-332052
|
|
1015858-38-4
|
|
Ethopropazine hydrochloride
|
|
1094-08-2
|
|
WAY-327449
|
|
693240-90-3
|
|
WAY-328173
|
|
912790-59-1
|
|
Vandortuzumab (anti-STEAP1)
|
|
1557989-52-2
|
|
lineal alkylbenzene
|
|
29986-57-0
|
|
Tesnatilimab (anti-NKG2D)
|
|
2242758-08-1
|
|
Dehydroepiandrosterone sulfate
|
|
651-48-9
|
|
WAY-333908
|
|
689269-24-7
|
|
Methyl 6-hydroxy-5-nitronicotinate
|
|
222970-61-8
|
|
WAY-332068
|
|
1015864-69-3
|
|
Telazorlimab (anti-TNFRSF4)
|
|
2126777-87-3
|
|
Fluorescein dibenzoate
|
|
7262-40-0
|
|
Nadecnemab (anti-GFRA3)
|
|
2377679-19-9
|
|
Beef extract desicxant
|
|
|
|
1-Boc-5-bromoindoline
|
|
261732-38-1
|